Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

888
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
888
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

79
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
79
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal overweight and obesity during pregnancy and sex-dependent dysregulation of the materno-fetal stress axis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Temporal Dynamics of Catestatin Across Gestation: Links to Metabolic and Hemodynamic Adaptation.

Life (Basel, Switzerland)·2026
Same author

Hyperspectral Fingerprints of Abdominal and Pelvic Organs.

Journal of imaging·2026
Same author

Maternal complications within six weeks after primary caesarean section in Ghana: a prospective cohort study.

BMC pregnancy and childbirth·2026
Same author

A cross-sectional study of caesarean deliveries performed by medical doctors and associate clinicians in nine district and regional hospitals in Sierra Leone using the Robson Ten Group Classification System.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Repeat cesarean delivery with hysterectomy: a sheep model to examine uterine scars.

Reproduction & fertility·2026

Related Experiment Video

Updated: Nov 10, 2025

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

11.6K

The relation between maternal obesity and placenta accreta spectrum: A multinational database study.

Matias C Vieira1,2,3, Marcus J Rijken4,5, Thorsten Braun6

  • 1Department of Obstetrics and Gynaecology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Acta Obstetricia Et Gynecologica Scandinavica
|April 3, 2021
PubMed
Summary

Maternal obesity is not an independent risk factor for placenta accreta spectrum (PAS) or its severity. This finding helps in accurately counseling pregnant women with obesity about pregnancy risks.

Keywords:
abnormally invasive placentabody mass indexobesityplacenta accreta spectrumpregnancy

More Related Videos

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

740
Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
05:44

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

843

Related Experiment Videos

Last Updated: Nov 10, 2025

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

11.6K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

740
Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
05:44

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

843

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • Obesity in pregnant women is associated with increased risks.
  • Placenta accreta spectrum (PAS) is a serious obstetric complication.
  • The independent association between maternal obesity and PAS is not well-established.

Purpose of the Study:

  • To investigate the association between maternal obesity and the risk of developing PAS.
  • To determine if maternal obesity is an independent risk factor for severe PAS (percreta).

Main Methods:

  • Cohort study utilizing the International Society for Placenta Accreta Spectrum (IS-PAS) database (April 2008 - May 2019).
  • Multivariable logistic regression adjusted for cesarean delivery, maternal age, and placenta previa.
  • Comparison of observed obesity rates in PAS cohort with estimated rates based on obesity-related cesarean delivery risk.

Main Results:

  • Of 386 women with PAS, 58.8% had severe disease (percreta).
  • Maternal obesity was initially associated with increased odds of percreta (OR 1.87), but this was not significant after adjustment (OR 1.44).
  • No significant difference was found between observed and estimated obesity rates (31.3% vs 36.8%, P=0.07).

Conclusions:

  • Maternal obesity does not appear to be an independent risk factor for PAS or its severity.
  • Findings support accurate counseling for pregnant women with obesity regarding pregnancy-related risks.